SBRA analyst estimates
Sabra Healthcare (SBRA) analyst ratings, the average price target and its range, and every firm's latest call.
SBRA analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 13, 2026 | UBS | Sabra Health Care price target lowered to $20 from $21 at UBS | $20.00 |
| Aug 31, 2026 | Barclays | Sabra Health Care price target raised to $23 from $21 at Barclays | $23.00 |
| Aug 31, 2026 | Mizuho Securities | Sabra Health Care price target raised to $21 from $20 at Mizuho | $21.00 |
| Jul 22, 2026 | Robert W. Baird | Sabra Health Care price target raised to $23 from $22 at Baird | $23.00 |
| Jul 22, 2026 | UBS | Sabra Health Care price target raised to $25 from $22 at Deutsche Bank | $25.00 |
| Jul 8, 2026 | Truist Financial | Sabra Health Care upgraded to Buy from Hold at Truist | $22.00 |
| Jul 7, 2026 | Barclays | Sabra Health Care initiated with an Equal Weight at Barclays | $21.00 |
| Jun 18, 2026 | UBS | Sabra Health Care price target lowered to $19 from $22 at Scotiabank | $19.00 |
| May 21, 2026 | Scotiabank | Sabra Health Care price target raised to $22 from $21 at Scotiabank | $22.00 |
| May 13, 2026 | UBS | Sabra Health Care price target raised to $22 from $21 at UBS | $22.00 |
| May 11, 2026 | Cantor Fitzgerald | Sabra Health Care price target raised to $22 from $21 at Cantor Fitzgerald | $22.00 |
| Feb 19, 2026 | UBS | Sabra Health Care price target raised to $21 from $20 at UBS | $21.00 |
| Feb 17, 2026 | Cantor Fitzgerald | Sabra Health Care price target raised to $21 from $20 at Cantor Fitzgerald | $21.00 |
| Jan 20, 2026 | Truist Financial | Sabra Health Care price target raised to $21 from $20 at Truist | $21.00 |
| Dec 15, 2025 | Jefferies | Sabra Health Care price target raised to $22 from $21 at Jefferies | $22.00 |
- 10 firms rate SBRA: 3 buy, 7 hold, 0 sell.
- The average price target is $21.86 from 7 analysts, from $20.00 to $23.00.
Updated 2026-11-07 11:53 UTC